AREDS2: Insights Into Optimal Supplements for AMD

by Medscape • 2013/05/20 • 0 Comments

The findings of the AREDS trials are put into perspective for clinicians.
Medscape Ophthalmology

← Recombinant human albumin from Novozymes Biopharma helps innovative dry eye therapy move into clinical trials

Subfoveal Choroidal Thickness in Diabetes and Diabetic Retinopathy – Corrected Proof →